| Literature DB >> 28108609 |
Liufeng Mao1, Baoming Nie2, Tao Nie1, Xiaoyan Hui3, Xuefei Gao4, Xiaoliang Lin5, Xin Liu6, Yong Xu1, Xiaofeng Tang1, Ran Yuan1, Kuai Li1, Peng Li1, Ke Ding1, Yu Wang1,3, Aimin Xu1,3, Jian Fei7, Weiping Han8, Pentao Liu4, Lise Madsen9,10,11, Karsten Kristiansen10,11, Zhiguang Zhou12, Sheng Ding13, Donghai Wu14,15.
Abstract
Both mammals and adult humans possess classic brown adipocytes and beige adipocytes, and the amount and activity of these adipocytes are considered key factors in combating obesity and its associated metabolic diseases. Uncoupling protein 1 (Ucp1) is the functional marker of both brown and beige adipocytes. To facilitate a reliable, easy, and sensitive measurement of Ucp1 expression both in vivo and in vitro, we generated a Ucp1-2A-luciferase knock-in mouse by deleting the stop codon for the mouse Ucp1 gene and replacing it with a 2A peptide. This peptide was followed by the luciferase coding sequence to recapitulate the expression of the Ucp1 gene at the transcriptional and translational levels. With this mouse, we discovered a cold-sensitive brown/beige adipose depot underneath the skin of the ears, which we named uBAT. Because of the sensitivity and high dynamic range of luciferase activity, the Ucp1-2A-luciferase mouse is useful for both in vitro quantitative determination and in vivo visualization of nonshivering thermogenesis. With the use of this model, we identified and characterized axitinib, an oral small-molecule tyrosine kinase inhibitor, as an effective browning agent.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28108609 DOI: 10.2337/db16-0343
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461